Biosimilar Battlefield: Samsung Bioepis Forecast
This Insight uses the biosimilar market model discussed in Surveying The Biosimilar Battlefield to build a long-term revenue forecast for the...
669 Views
Surveying The Biosimilar Battlefield
The biosimilar market has been of particular interest to us in light of the high expectations set for Samsung Biologics Co., Ltd (207940 KS) and...
890 Views
Daiichi Sankyo (4568) - Is Luck Running Out?
Daiichi Sankyo (4568 JP) has been seen as leading something of a charmed life in recent months, most notably when Sun Pharmaceutical (SUNP IN) paid...
285 Views